{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:27:37Z","timestamp":1792783657571,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Summit Therapeutics"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.anaerobe.2016.04.013","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T17:01:19Z","timestamp":1461949279000},"page":"10-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A novel method for imaging the pharmacological effects of antibiotic treatment on Clostridium difficile"],"prefix":"10.1016","volume":"40","author":[{"given":"Bradley T.","family":"Endres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Bass\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Memariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jahangir","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis A.","family":"Kakadiaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2063-7503","authenticated-orcid":false,"given":"Kevin W.","family":"Garey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2016.04.013_bib1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1517\/13543784.2010.495386","article-title":"Future novel therapeutic agents for Clostridium difficile infection","volume":"19","author":"Koo","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.anaerobe.2016.04.013_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1586\/eri.10.28","article-title":"Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance","volume":"8","author":"Shah","year":"2010","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3201\/eid1406.071447","article-title":"Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005","volume":"14","author":"Zilberberg","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib5","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/AAC.01623-06","article-title":"In\u00a0vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004","volume":"51","author":"Hecht","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1128\/AAC.49.3.1157-1159.2005","article-title":"In\u00a0vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole","volume":"49","author":"Pelaez","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib7","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1128\/IAI.00551-09","article-title":"Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1","volume":"77","author":"Goulding","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib8","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1093\/jac\/dku261","article-title":"Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison","volume":"69","author":"Cornely","year":"2014","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/BF01967563","article-title":"Structure, biochemistry and mechanism of action of glycopeptide antibiotics","volume":"8","author":"Reynolds","year":"1989","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/09553007914551151","article-title":"Mechanism of action of nitroimidazole antimicrobial and antitumour radiosensitizing drugs. Effects of reduced misonidazole on DNA","volume":"36","author":"Knight","year":"1979","journal-title":"Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/jac\/dkv498","article-title":"Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection","volume":"71","author":"Basseres","year":"2016","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib12","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.1128\/AEM.00754-06","article-title":"Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut","volume":"72","author":"Macfarlane","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib13","first-page":"e52122","article-title":"High resolution electron microscopy of the Helicobacter pylori Cag type IV secretion system pili produced in varying conditions of iron availability","author":"Haley","year":"2014","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib14","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jac\/dkv006","article-title":"In\u00a0vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile","volume":"70","author":"Corbett","year":"2015","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000104471","article-title":"Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile","volume":"53","author":"Odenholt","year":"2007","journal-title":"Chemotherapy"},{"key":"10.1016\/j.anaerobe.2016.04.013_bib16","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1128\/JB.00038-14","article-title":"Identification and characterization of a gene cluster required for proper rod shape, cell division, and pathogenesis in Clostridium difficile","volume":"196","author":"Ransom","year":"2014","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib17","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1128\/AEM.03446-14","article-title":"Use of mCherry Red fluorescent protein for studies of protein localization and gene expression in Clostridium difficile","volume":"81","author":"Ransom","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A\u00a0comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.anaerobe.2016.04.013_bib19","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1093\/cid\/cis358","article-title":"Fidaxomicin is an inhibitor of the initiation of bacterial RNA synthesis","volume":"55","author":"Artsimovitch","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib20","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2174\/138920111796117382","article-title":"Glycopeptide antibiotics and their novel semi-synthetic derivatives","volume":"12","author":"Jeya","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib21","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile\u2013more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib22","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1093\/jac\/dkv156","article-title":"Efficacy of alternative fidaxomicin dosing regimens for treatment of simulated Clostridium difficile infection in an in\u00a0vitro human gut model","volume":"70","author":"Chilton","year":"2015","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2016.04.013_bib23","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1128\/AAC.01087-15","article-title":"Mode of action and bactericidal properties of surotomycin against growing and nongrowing Clostridium difficile","volume":"59","author":"Alam","year":"2015","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996416300403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996416300403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T05:05:35Z","timestamp":1655615135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996416300403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":23,"alternative-id":["S1075996416300403"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2016.04.013","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel method for imaging the pharmacological effects of antibiotic treatment on Clostridium difficile","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2016.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}